Quest Diagnostics Incorporated (DGX) EV/EBITDA Multiple

DGX (Quest Diagnostics) - company brandmark

The EV/EBITDA multiple on the time chart in the GURU.Markets terminal demonstrates the strategy of Quest Diagnostics (DGX) to capture market share by acquiring loss-making laboratories and implementing AI-driven tests. Large-scale robotization of sample sorting and digital data analysis optimize processes. The 14.90 metric indicates the status of a company whose revenue relies on stable settlements with US insurance behemoths and hospitals.

DGX Quest: Total Company Value to Operating Income Before Depreciation Ratio in the range 11/23/2025 - 11/10/2026

Metric breakdowns and analytics for questdiagnostics.com (DGX)

- market price and analyst price targets:
Price Chart Quest|DGX - Analyst Median Target
- market capitalization details:
Market Capitalization Quest Corp|DGX - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Quest Diagnostics|DGX - Book Valuation of Business|Market Value to Book Value Ratio questdiagnostics.com|DGX - Company Balance Sheet Assets
- company liabilities and liquidity data:
Total Debt to Equity Ratio Quest Diagnostics|DGX - Long-Term Debt to Capital|Short-Term Debt to Capital Quest Diagnostics Incorporated|DGX - Company Cumulative Debt|Debt to Book Capitalization Ratio Quest Corp|DGX - Long-Term Debt Volume|Company Current Liabilities Quest Diagnostics|Quick Liquidity Indicator questdiagnostics.com
- business earnings and investment ratios data:
DGX - Final Profit|Projected Future Earnings Quest Diagnostics|DGX - Price to Earnings Multiple|Forward P/E Multiple Quest Diagnostics|DGX - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Quest Corp|DGX - Operating profit EBITDA|Net earnings per share (EPS TTM) Quest Diagnostics|DGX - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months questdiagnostics.com|DGX - Earnings per share growth this year|Net earnings per share growth forecast for next year Quest Diagnostics
Initial company analysis:DGX (Quest)
Manufactured products of questdiagnostics.com

Investors are assessing the resilience of Quest Diagnostics (DGX) through the lens of debt load and operational efficiency. The multiple correlates the total enterprise value, including debt, with earnings before interest, taxes, depreciation, and amortization, revealing the asset's true value. Analyzing the business valuation via the EV/EBITDA ratio provides insight into how the company withstands the pressure of government tariffs and competition from startups. Low values may signal either an undervaluation or systemic risks within the model.

Analysis of competing companies

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Agilent Tech A|Total Company Value to Operating Income Before Depreciation Ratio Illumina Platform (ILMN)|Exact Sciences - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio revvity.com RVTY|Bio-Rad (BIO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NNNN - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sterigenics|QDEL - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio OPK (OPKO Health, Inc.)|EV/EBITDA Multiple CareDx, Inc. (CDNA)|EV/EBITDA Multiple MRVI (Maravai LifeSciences Holdings, Inc.)|Fulgent Genetics Inc (FLGT) - Company Value to EBITDA|LAB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Cytek Corp CTKB|OSUR (OraSure Technologies) - Enterprise Value to EBITDA Ratio|XGN: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MDXH|LUCD: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple PRE|imdxinc.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple TRIB (Trinity Biotech)|Total Company Value to Operating Income Before Depreciation Ratio prophaselabs.com (PRPH)|Ainos - EV/EBITDA Multiple|CODX - EV/EBITDA Multiple|HSCS: EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Biomerica Inc BMRA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cardio Diagnostics Holdings Inc.|Enterprise Value to Operating Income Before Depreciation ONCO (onconetix.gcs-web.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Virax Biolabs (VRAX)|BJDX - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vermillion AWH|Total Company Value to Operating Income Before Depreciation Ratio Accelerate Diagnostics Inc (AXDX)|CNTG: Enterprise Value to EBITDA Ratio|Enzo Biochem, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|FRES: EV/EBITDA Multiple|GENE - Total Company Value to Operating Income Before Depreciation Ratio|ME (23andMe Inc.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Psychemedics Inc (PMD)